Health-care decision-making processes in Latin America: Problems and prospects for the use of economic evaluation

International Journal of Technology Assessment in Health Care

Volumn 21, Issue 1, 2005, Pages 1-14

  Iglesias, Cynthia P ^a   Drummond, Michael F ^a   Rovira, Joan ^b,c  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

^c University of York ^*  (Spain)

Author keywords

Decision making; Economic evaluation; Latin america; Review; Survey

Indexed keywords

DECISION MAKING; INDUSTRIAL ECONOMICS; MEDICINE; PROFESSIONAL ASPECTS; QUALITY ASSURANCE;

CLINICAL EFFICACY; ECONOMIC EVALUATION (EE); HEALTH-CARE SYSTEM; LATIN AMERICAN (LA);

HEALTH CARE;

ARGENTINA; ARTICLE; COLOMBIA; COMPARATIVE STUDY; CUBA; DECISION MAKING; ECONOMIC EVALUATION; EUROPE; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH ECONOMICS; MEXICO; NICARAGUA; PERU; POLITICS; PORTUGAL; PUBLIC HEALTH SERVICE; RESOURCE MANAGEMENT; SPAIN; UNITED KINGDOM; URUGUAY; VENEZUELA;

EID: 13644265590     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462305050014     Document Type: Article

References (23)

1. Alcázar Valdivia L, Balcázar Suárez RA, Francke Ballve P, et al. Impacto económico de la Malaria en el Perú. Convenio de cooperación entre el Ministerio de Salud del Perú y la Agencia de los Estados Unidos para el Desarrollo Internacional, (USAID). Lima Perú: USAID; 1999.
2. Australian Pharmaceutical Benefits Advisory Committee. Available at: www.health.gov.au/pbs/general/listing/committee. htm.
3. Balcazar Suarez RA, Francke Ballve P, Portocarrero GA, et al. Impacto económico de la tuberculosis en Perú. Ministerio de Salud. Proyecto Vigia. Lima Perú: USAID; 1999.
4. BIREME. Latin American and Caribbean Health Sciences Literature (LILACS), 2003. Available at: http://www.bireme. br/bvs.
5. Cataño C, Rojas G. Evaluación costo-eficiencia de estrategias de control y prevención de la malaria en comunidades de la costa pacífica colombiana. Facultad de Ciencias Económicas. Universidad de Antioquia. Medellín, Colombia: 1992:49.
6. Cook JR, Drummond M, Glick H, Heyse JF. Assessing the appropriateness of combining economic data from multinational clinical trials. Stat Med. 2003,22:1955-1976.
7. CRD. NHS Economic Evaluation Database (NHS EED). United Kingdom: Centre for Reviews and Dissemination, University of York; 2003.
8. Drummond M, Dubois D, Garattini L, et al. Current trends in the use of pharmacoeconomics and outcomes research in Europe. Value Health. 1999;2:323-332.
9. Drummond M, Pang F. Transferability of economic evaluation results. In: Drummund M, McGuire A, eds. Economic evaluation in health care-Merging theory with practice. Chapt. 11. Oxford: Oxford University Press/Office of Health Economics; 2001.
10. Galvez AM, Gálvez M, Sanabria G. Economic evaluation alongside an antenatal trial in developing countries. Report on Cuba. HPP Report Series. Norfolk, UK: UEA Norwich School of Health Policy and Practice.
11. Institute Nacional da Farmácia e do Medicamento. Available at: www.infarmed.pt.
12. Kielhorn A, Graf von der Schulenburg J-M. The health economics handbook. Adis International; 2000.
13. Martínez Ravelo R, Rivalta del Sol D, Peña Gallo A, Díaz Machado O. El costo en un hospital pediátrico. Rev Cuba Pediatría. 1989;61:675-681.
14. Nunes A. O Impacto Econômico da AIDS/HIV no Brasil. Texto para discussãon 505. Agosto 1997. Brasil: IPEA.
15. OHE-IFPMA. Health economic evaluation database (HEED). London: Office for Health Economics; 2003.
16. Pan American Health Organization. Country specific profile of health services system: Program on organization and management of health systems and services division of health systems and services development. PAHO; 1998-1999.
17. Pan American Health Organization. Health in the Americas. PAHO; 1998.
18. Rodríguez M, Soler A, Deleón G, et al. Impacto económico y relación costo efectividad Unidad de Medicina Intensiva. 1995;3:147.
19. Salinas Ortiz J, Sánchez Módena C, Recuenco S. Estudio de costos y evaluación de estrategias para la prevención y control de la fiebre amarilla en el Perú (Informe final). Lima: Ministerio de Salud, Proyecto Vigia; 2000.
20. Sanabria C. Estudio de costos del Programa de Atención Integral de Salud (PAIS) en las poblaciones de las Comunidades Indígenas del Alto Amazonas. Perú: Ministerio de Salud del Perú, Dirección Regional de Salud de Loreto (informe parcial); 2001.
21. The National Drug Scheduling Advisory Committee. Available at: www.napra.org.
22. The National Institute for Clinical Excellence. Available at: www.nice.org.uk.
23. Ugá MAD. Economic analysis of the vaccination strategies adopted in Brazil in 1982. Boletim da OPAS. Brazilia: OPAS; 1988: 22.